This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Limited doses of immunotherapy use in advanced non‐small cell lung cancer elderly patients with ECOG of 2 and high PDL‐1 expression. Issue 4 (24th October 2021)
Record Type:
Journal Article
Title:
Limited doses of immunotherapy use in advanced non‐small cell lung cancer elderly patients with ECOG of 2 and high PDL‐1 expression. Issue 4 (24th October 2021)
Main Title:
Limited doses of immunotherapy use in advanced non‐small cell lung cancer elderly patients with ECOG of 2 and high PDL‐1 expression
Abstract : Immunotherapy is an effective treatment in advanced non‐small cell lung cancer (NSCLC) patients with high PDL‐1 expression. Here, we report three such patients with durable response despite limited doses immunotherapy.